Podrobno

Transient HA-100 exposure improves aggregate uniformity and cell-cell contact stability in suspension human pluripotent stem cell cultures
ID Khurana, Preeti (Avtor), ID Liović, Mirjana (Avtor), ID Ilic, Dusko (Avtor), et al.

.pdfPDF - Predstavitvena datoteka, prenos (2,43 MB)
MD5: 0F029B916C124F515452D846B01B6B91
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S1465324926008650 Povezava se odpre v novem oknu

Izvleček
Background aims: Human pluripotent stem cell (hPSC) manufacturing workflows frequently rely on suspension aggregation, yet inter-line and batch-to-batch variability in aggregate formation can compromise process consistency and downstream differentiation performance. We evaluated whether a short exposure to HA-100, a small-molecule inhibitor of protein kinase A and protein kinase C signaling, could be used as an upstream process intervention to improve aggregate uniformity without compromising hPSC identity or developmental competence. Methods: Nine hPSC lines, including human embryonic stem cell and induced pluripotent stem cell lines, were examined in suspension culture. HA-100 was applied during the first 24 h of aggregation. Aggregate morphology and size distribution were assessed across lines. To investigate the cellular basis of this effect, we generated an mCherry-TJP1 reporter hESC line, which enabled live visualization of junction dynamics, including responses under calcium-depleted conditions and recovery of transepithelial electrical resistance. Results: HA-100 treatment promoted more compact and spherical aggregates, increased aggregate size into a narrower range across lines, and reduced overall variability relative to medium alone. Across the nine-line panel, HA-100-treated aggregates fell within an empirically definesd size range of 25.37-33.95 x 10^-4 mm^3 after 24 h of suspension culture, providing a practical benchmark for process monitoring. In calcium-depleted conditions, HA-100 delayed disruption of intercellular contacts and accelerated recovery of transepithelial electrical resistance, consistent with improved junctional resilience. Transient exposure to HA-100 did not abolish pluripotency marker expression or tri-lineage differentiation capacity. Conclusions: These data support HA-100 as a practical upstream intervention to reduce aggregate heterogeneity in suspension hPSC cultures and improve reproducibility in manufacturing-oriented workflows requiring consistent aggregation.

Jezik:Angleški jezik
Ključne besede:human pluripotent stem cells, suspension culture, aggregate uniformity, HA-100, manufacturing, TJP1
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:7 str.
Številčenje:Vol. 28, iss. 9, art. 102904
PID:20.500.12556/RUL-185452 Povezava se odpre v novem oknu
UDK:61:602.9:57.086.83
ISSN pri članku:1477-2566
DOI:10.1016/j.jcyt.2026.102904 Povezava se odpre v novem oknu
COBISS.SI-ID:279909891 Povezava se odpre v novem oknu
Datum objave v RUL:06.08.2026
Število ogledov:67
Število prenosov:33
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Cytotherapy
Skrajšan naslov:Cytotherapy
Založnik:Elsevier, International Society for Cell & Gene Therapy
ISSN:1477-2566
COBISS.SI-ID:521762329 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:človeške pluripotentne matične celice, suspenzijska kultura, enakomernost agregatov, proizvodnja

Projekti

Financer:Leo Foundation Denmark
Številka projekta:LF16028

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Department of Veterans Affairs, Biomedical Laboratory Research & Development
Številka projekta:I01BX006094
Naslov:VA Merit Award

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J3-3078
Naslov:EB adhesom kot potencialna tarča za nove terapevtske pristope

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J3-50121
Naslov:Mehanotransdukcija pri bulozni epidermolizi tipa simpleks

Financer:NIH - National Institutes of Health
Številka projekta:1R01EB018842-01
Naslov:Mechanisms of nanostructure-enhanced transepithelial drug delivery

Financer:Foundation Charite, Berlin

Financer:Li Foundation fellowship

Financer:UKRI - UK Research and Innovation
Številka projekta:MR/W006693/1
Naslov:WNT signalling in human trophectoderm development

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj